Pfizer’s lymphoma drug successfully tested
The Pfizer company informed that its drug, “Adcetris”, extended survival in patients with the most common type of lymphoma in a late-stage study of the disease, Reuters reported. Lymphoma is an Oncological disease in which the lymphoid tissue is the source of a malignant tumor. The New York-based drug-maker last year struck a deal to…